Add like
Add dislike
Add to saved papers

Regulation by sulfanylurea receptor type 1 of a non-selective cation channel involved in cytotoxic edema of reactive astrocytes.

Hypoxia-ischemia and ATP depletion are associated with cytotoxic edema of glial cells, but mechanisms involved remain incompletely characterized. We examined morphologic and electrophysiological responses of freshly isolated native reactive astrocytes (NRAs) following exposure to NaN3, which depletes cellular ATP. NaN3 caused profound and sustained depolarization due to activation of a novel 35 pS Ca2+-activated, [ATP]i-sensitive non-selective cation (NCCa-ATP) channel found in >90% of excised membrane patches. This channel exhibited significantly different properties compared with previously reported NCCa-ATP channels, including different sensitivity to block by various adenine nucleotides (EC50=0.79 microM for [ATP]i, with no block by AMP or ADP), and activation by submicromolar [Ca]i. In addition, the channel was found to be regulated in a manner identical to that of SUR1-regulated KATP channels, including high affinity block by glybenclamide and tolbutamide, and opening by diazoxide. mRNA transcription and protein expression of SUR1 but not SUR2 were confirmed in reactive astrocytes both in situ and after isolation, whereas Kir6.x, which forms the pore-forming subunit of the KATP channel, was not expressed. Channel opening by [ATP]i depletion or exposure to diazoxide caused blebbing of the cell membrane, whereas [ATP]i depletion in the presence of glybenclamide did not. These findings are consistent with participation of this channel in cation flux involved in cell swelling. This novel channel may play an important role in the pathogenesis of brain swelling.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app